astrazeneca - Search News

News

CSPC, AstraZeneca

AstraZeneca and CSPC Pharmaceuticals enter AI-driven partnership worth $5.3bn

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for chronic conditions.

The Wall Street Journal on MSN · 3d

AstraZeneca Enters Deal With CSPC Pharma Valued at Up to $5.33 Billion

The deal with China’s CSPC Pharmaceuticals, focused on AI-driven research, aims to advance the discovery and development of new drug candidates.

Reuters on MSN · 2d

AstraZeneca signs AI research deal with China's CSPC for chronic diseases

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for chronic conditions,

Fierce Pharma21m

AstraZeneca touts early Ultomiris survival data in children living with rare post-transplant complication

Now that Ultomiris has matched the indications of its predecessor Soliris, AstraZeneca is eyeing new avenues for the C5 drug ...

2h

EHA 2025: AstraZeneca’s surovatamig is potential next-gen BiTE for R/R B-ALL

This trial evaluated the safety, tolerability, pharmacodynamics, pharmacokinetics and clinical activity of AstraZeneca’s ...

The Pharma Letter5h

AstraZeneca’s Ultomiris shows strong OS in HSCT TMA

Initial results from the ALXN1210-TMA-314 Phase III trial showed that UK pharma major AstraZeneca’s Ultomiris (ravulizumab) ...

4d

AstraZeneca Unit Owes $180 Million-Plus in Syntimmune Case (1)

An AstraZeneca Plc affiliate suffered a greater than $180 million court loss Wednesday over its lackluster efforts to ...

AstraZeneca sues Utah attorney general over new Utah drug price law

The pharmaceutical drug company AstraZeneca filed a lawsuit against the Utah attorney general claiming Utah's new law on ...

1d

AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer

AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, the first patient was dosed by ...

BioPharma Dive3d

AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans

AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...

AstraZeneca encouraged to build pharmaceutical manufacturing plant in Vietnam

VOV.VN - Prime Minister Pham Minh Chinh has proposed that AstraZeneca consider building a pharmaceutical manufacturing plant ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results